Search

Your search keyword '"Lung Diseases, Interstitial genetics"' showing total 59 results

Search Constraints

Start Over You searched for: Descriptor "Lung Diseases, Interstitial genetics" Remove constraint Descriptor: "Lung Diseases, Interstitial genetics" Publisher american thoracic society Remove constraint Publisher: american thoracic society
59 results on '"Lung Diseases, Interstitial genetics"'

Search Results

1. Progressive Early Interstitial Lung Abnormalities in Persons at Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study.

2. Preacinar Arterial Dilation Mediates Outcomes of Quantitative Interstitial Abnormalities in the COPDGene Study.

Catalog

Books, media, physical & digital resources

4. Proteomic Biomarkers of Quantitative Interstitial Abnormalities in COPDGene and CARDIA Lung Study.

5. The Genetic Landscape of Familial Pulmonary Fibrosis.

7. Progressive Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis.

8. Suspected Interstitial Lung Disease in COPDGene Study.

9. Heterogenous Disease Course and Long-Term Outcome of Children's Interstitial Lung Disease Related to Filamin A Gene Variants.

10. The Proteomic Profile of Interstitial Lung Abnormalities.

13. Use of a Genomic Classifier in Patients with Interstitial Lung Disease: A Systematic Review and Meta-Analysis.

14. High-Content Screening Identifies Cyclosporin A as a Novel ABCA3-Specific Molecular Corrector.

15. Prospective Identification of Subclinical Interstitial Lung Disease in a Rheumatoid Arthritis Cohort Is Associated with the MUC5B Promoter Variant.

16. Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular Signatures.

17. Air Pollution and Interstitial Lung Diseases: Defining Epigenomic Effects.

18. Functional Genomics of ABCA3 Variants.

19. Successful Treatment of Interstitial Lung Disease in STAT3 Gain-of-Function Using JAK Inhibitors.

20. Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease.

21. Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.

22. Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.

23. Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality.

24. Telomeres in Interstitial Lung Disease: The Short and the Long of It.

25. STAT3 Gain of Function: A New Kid on the Block in Interstitial Lung Diseases.

26. Interstitial Lung Disease Caused by STING-associated Vasculopathy with Onset in Infancy.

27. Persistent Lung Disease in Adults with NKX2.1 Mutation and Familial Neuroendocrine Cell Hyperplasia of Infancy.

28. Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs.

29. Rare variants in RTEL1 are associated with familial interstitial pneumonia.

31. Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease.

32. Update in diffuse parenchymal lung disease, 2013.

33. Genotype-phenotype correlations for infants and children with ABCA3 deficiency.

34. Novel mutation in ABCA3 resulting in fatal congenital surfactant deficiency in two siblings.

35. Large ABCA3 and SFTPC deletions resulting in lung disease.

36. Animal models of fibrotic lung disease.

38. Autoreactive T and B cells induce the development of bronchus-associated lymphoid tissue in the lung.

39. The genetic and environmental causes of pulmonary fibrosis.

40. Let It Be: microRNAs impact interstitial lung disease.

41. Genetic analysis of sporadic and familial interstitial pneumonia.

42. Update in pediatric lung disease 2007.

43. A new missense mutation in the CASR gene in familial interstitial lung disease with hypocalciuric hypercalcemia and defective granulocyte function.

44. Gene expression profiling of familial and sporadic interstitial pneumonia.

45. Expression profiling in granulomatous lung disease.

47. Clinical Year in Review IV: Interstitial lung disease, cystic fibrosis, pulmonary infections, and mycobacterial disease.

49. Clinical and pathologic features of familial interstitial pneumonia.

50. Surfactant dysfunction mutations in children's interstitial lung disease and beyond.